
Investigating whether copper disruption links key MS risk factors
MS Australia’s latest $2.8m research grant round addresses a long-standing gap in multiple sclerosis (MS) genetics and projects that slow...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Discover our latest videos on the Perron Institute YouTube channel. See the Perron Institute’s appearances in the media here.

MS Australia’s latest $2.8m research grant round addresses a long-standing gap in multiple sclerosis (MS) genetics and projects that slow...

New data from AI-driven re-analysis of the Phase 2 clinical trial results by Argenica Therapeutics has confirmed that the neuroprotective...

Support Perron Institute in the HBF Run for a Reason 2026 The HBF Run for a Reason returns on Sunday...

With deep respect and gratitude, the Perron Institute acknowledges the death of Emeritus Professor Bryant Stokes AO, a revered neurosurgeon whose outstanding contributions have had a massive impact on medical...

Building community capacity in end-of-life care and dispelling misconceptions are themes of a recently published editorial in the journal Palliative Care and Social Practice. Co-author...

The Member of the Order of Australia (AM) honour awarded to Professor Minghao Zheng AM for advancement of regenerative medicine...

Developing a personalised prescribing model to improve treatment for depression and anxiety is the aim of a leading-edge mental health...

The Motor Neurone Disease Association of Western Australia (MNDAWA) Life Membership is awarded in recognition for providing extraordinary service to the Association over a period...

Western Australia’s Perron Institute has recently appointed two non-Executive Directors, each with an impressive record of achievement in their fields of expertise. Paul Anderson has 25 years’ experience in...

Research on genetic causes of dystonia in Australian families affected by this severely disabling neurological movement disorder has received support under the 2025-26 WA Government’s Future...

The rapidly evolving field of precision medicine and how it is reshaping the understanding and treatment of motor neurone disease (MND) is explored in a recent review led by researchers in Western Australia as...

The protocol of an Australian-first pilot study based at the Perron Institute in Western Australia which explores the efficacy of personalised antidepressants in young people with major depressive disorder (MDD) has been published. ...
Stay up to date with our latest news and announcements.